- Pharmaceutical companies
- North America
- Mexico
- Novartis
Novartis in Mexico
Addresses:
-
Novartis Corporativo, S.A. de C.V., Calzada Tlalpan No. 1779, Col. San Diego Churubusco, Delegación Coyoacán, 04120 Ciudad de México, Mexico
Web: https://www.novartis.com.mx
Phone: 52 55 5420 8700
Fax: 52 55 5544 1720
-
Novartis Farmacéutica, S.A. de C.V., Calzada Tlalpan No. 1779, Col. San Diego Churubusco, Delegación Coyoacán, 04120 Ciudad de México, Mexico
Web: https://www.novartis.com.mx
Phone: 52 55 5420 8600
-
Sandoz, S.A. de C.V., Calzada Tlalpan No. 1779, Col. San Diego Churubusc, , Delegación Coyoacán, 04120 Ciudad de México, Mexico
Phone: 52 55 5420 8600
-
Sandoz, S.A. de C.V., La Candelaria No. 186, Colonia Atlántida, Delegación Coyoacán, 04370 Ciudad de México, Mexico
Web: https://www.novartis.com.mx
Phone: 52 55 5549 3740
Fax: 52 55 5544 0581
Other Novartis's locations around the world
-
Switzerland
-
Austria
-
Germany
-
Slovenia
-
Poland
-
France
-
Spain
-
Belgium
-
Romania
-
Italy
-
United Kingdom
-
Ukraine
-
Russia
-
Serbia
-
Slovakia
-
Sweden
-
Belarus
-
Bulgaria
-
Croatia
-
Czech Republic
-
Denmark
-
Estonia
-
Finland
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Latvia
-
Lithuania
-
Luxembourg
-
Macedonia
-
Malta
-
Montenegro
-
Netherlands
-
Norway
-
Portugal
-
Albania
-
Bosnia & Herzegovina
Clinical Trials sponsored by Novartis
-
Novartis PharmaceuticalsNoch keine RekrutierungMultiple Sklerose, schubförmig remittierend
-
Novartis PharmaceuticalsNoch keine RekrutierungRheumatoide Arthritis | Systemischer Lupus erythematodes | Sjögrens-Krankheit
-
Novartis PharmaceuticalsNoch keine RekrutierungErhöhter Lp(a) und etablierte atherosklerotische Herz-Kreislauf-Erkrankung
-
Novartis PharmaceuticalsRekrutierungSchubförmige Formen der Multiplen SkleroseSpanien
-
Novartis PharmaceuticalsRekrutierung
-
Novartis PharmaceuticalsNoch keine Rekrutierung
-
Novartis PharmaceuticalsRekrutierungMultiple Sklerose (MS)Frankreich
-
Novartis PharmaceuticalsNoch keine Rekrutierung
-
Novartis PharmaceuticalsRekrutierungHR+HER2 – fortgeschrittener BrustkrebsRussische Föderation
-
Novartis PharmaceuticalsRekrutierungKoronare Herzerkrankung | Klonale Hämatopoese mit unbestimmtem Potenzial (CHIP)Deutschland, Kanada
About Novartis
Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. Our purpose is to reimagine medicine to improve and extend people's lives. We use innovative science and technology to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to reward those who invest their money, time and ideas in our company.